Studies of axitinib and axitinib drug combinations as BCR-ABL1 T315I -selective therapies for use in drug-resistant CML and Ph+ ALL
- Wennerberg, Krister (Project manager)
- Repasky, Gretchen (Participant)
- Pemovska, Tea, (Participant)
- Porkka, Kimmo (Project manager)